Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rohrabacher substitute patent amendment to HR 400 rejected by 178-227 House vote.

This article was originally published in The Tan Sheet

Executive Summary

REP. ROHRABACHER SUBSTITUTE PATENT AMENDMENT DEFEATED BY 178-227 VOTE during House consideration of Rep. Howard Coble's (R-N.C.) Patent & Trademark Office reform package (HR 400) on April 17. The House plans to continue consideration of HR 400 on April 23. Ten amendments, including the manager's amendment sponsored by Coble, are pending, although more could be introduced under the bill's open rule.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086946

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel